Francesco Patti
Catania, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 412 publications
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 03, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 21, 2026
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 04, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 02, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.
Journal: Neurology and therapy
Published: June 01, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.
Journal: Neurology
Published: May 29, 2026
AI-based predictive biomarkers for chronic neurological diseases: the rAIdD prospective, multicenter, observational study protocol.
Journal: Frontiers in neurology
Published: May 19, 2026
Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS Study.
Journal: Neurology and therapy
Published: March 26, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
Journal: Brain : a journal of neurology
Published: March 12, 2026
Threshold-Dependent Discordance Between STRATIFY JCV™ and IMMUNOWELL™ Assays in Relapsing Multiple Sclerosis.
Journal: Neurology and therapy
Published: February 23, 2026
Last Updated: 09/26/2026